Page 17 - Pathogen Readiness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HMS Dean Outlines Financial, Institutional Goals in State of the School Address | News | The Harvard Crimson

In the three months since Johnson & Johnson’s COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration, more than 10 million Americans have received the vaccine, according to the Centers for Disease Control and Prevention. The single-shot viral vector vaccine — developed in collaboration with Beth Israel Deaconess Medical Center (BIDMC) immunologist Dan Barouch — was authorized for use based on clinical trial data showing strong clinical efficacy against symptomatic COVID-19 in the United States, Latin America and South Africa. In a new study publ...

This article is part of Harvard Medical School's continuing coverage of medicine, biomedical research, medical education, and policy related to the...

BOSTON – In the three months since Johnson & Johnson's COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration,...

Harvard holds its first virtual alumni association annual meeting—with a powerful guest speaker.